CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jan 26, 00:27

Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed?

Vir Biotechnology Inc
Webhose 2026 Jan 23, 15:08

Vir Biotechnology (VIR) Is Up 19.4% After Strong Dual-Therapy Data in Hepatitis Delta Trial

Vir Biotechnology Inc
Webhose 2026 Jan 23, 12:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2026 Jan 23, 09:40

A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates

Vir Biotechnology Inc
Webhose 2026 Jan 21, 20:33

Vir Biotechnology (NASDAQ:VIR) Shares Up 9.9% - Should You Buy?

Vir Biotechnology Inc
Webhose 2026 Jan 20, 19:00

Reviewing Vir Biotechnology (NASDAQ:VIR) and Creative Medical Technology (NASDAQ:CELZ) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jan 13, 22:38

Vir Biotechnology (NASDAQ:VIR) Trading 7.3% Higher - What's Next?

Vir Biotechnology Inc
Webhose 2026 Jan 13, 14:38

Vir Biotechnology (NASDAQ:VIR) Trading Up 7.3% - Should You Buy? - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jan 08, 02:26

Vir Biotechnology (NASDAQ:VIR) Director Sells $130,460.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jan 05, 21:10

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2026 Jan 05, 20:45

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology Inc
Webhose 2026 Jan 05, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 Jan 03, 09:16

Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $17.30 - Markets Daily

Vir Biotechnology Inc
Webhose 2025 Dec 30, 18:36

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 3.4% - Here's What Happened

Vir Biotechnology Inc

VirBiotechnology news

Latest news

Show more

Info

Spread

0.06

Spread (%)

0.7792 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1053176448

Shares Outstanding

139125032

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.62

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot